Discussion on WHO GPhP and the Significance to the Practice of Chinese Pharmacopoeia

Wang Xiaojuan, Cao Yan, Ma Rui, Xu Li, Guo Zhongping

Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (10) : 1158-1164.

PDF(1192 KB)
PDF(1192 KB)
Chinese Pharmaceutical Affairs ›› 2017, Vol. 31 ›› Issue (10) : 1158-1164. DOI: 10.16153/j.1002-7777.2017.10.011
Standard Research

Discussion on WHO GPhP and the Significance to the Practice of Chinese Pharmacopoeia

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 31(10): 1158-1164 https://doi.org/10.16153/j.1002-7777.2017.10.011

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1192 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉